UPS, in the throes of a cost-cutting drive, said Tuesday that it had reduced its workforce by 48,000 employees this year. The ...

Researchers investigating drugs such as Ozempic and Mounjaro have discovered a crucial detail about how they affect alcohol ...

PHOENIX -- Use of tirzepatide (Mounjaro, Zepbound) was associated with significantly lower risks of death, hospitalization, ...

Preliminary studies suggest GLP-1s may offer long-term protection against the eye disease AMD for people without diabetes.

Somehow, it’s becoming even harder to get a GLP-1.

A Gallup poll suggests nearly 8 million fewer people are obese than in 2022 — a drop that coincides with the surging use of ...

Diabetes has reached an all-time high despite a “statistically meaningful decrease” in the adult obesity rate, Gallup ...

Until recently, GLP -1s, a powerful new class of weight-loss drugs, were confined mostly to rich countries. Yet the World ...

GLP-1 receptor agonists show promise in treating various chronic conditions, but potential risks and unanswered questions remain for care of patients with NETs.

LOUISVILLE, KY. — A panel representing retail and food processing discussed consumer insights at the recent American Egg Board and United Egg Producers annual joint executive conference in Louisville, ...

The cost of employer-sponsored health insurance rose for the third year in a row in 2025, approaching an average of almost $27,000 for a family plan, according to an annual survey from KFF released ...

Research has suggested the potential of GLP-1 medications for treating substance use disorders, including alcohol, opioids, ...